Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
This study is ongoing, but not recruiting participants.
Study NCT00343421 Information provided by Sanofi-Aventis
First Received: June 21, 2006 Last Updated: April 7, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Tetanus
Pertussis
Poliomyelitis
Haemophilus Influenzae Type B
Additional conditions recognized in this trial
Influenza, Human
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Motor Neuron Disease
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Orthomyxoviridae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
PEDIACEL® and Prevenar®
Infanrix®-IPV+Hib and Prevenar®
Sponsors listed in this trial
Sanofi-Aventis
Back to top of Main Content
